181 related articles for article (PubMed ID: 34626502)
21. Efficacy and safety of tanezumab, NSAIDs, and placebo in patients with moderate to severe hip or knee osteoarthritis and a history of depression, anxiety, or insomnia: post-hoc analysis of phase 3 trials.
Mease P; Kuritzky L; Wright WL; Mallick-Searle T; Fountaine R; Yang R; Sadrarhami M; Faison W; Johnston E; Viktrup L
Curr Med Res Opin; 2022 Nov; 38(11):1909-1922. PubMed ID: 35980115
[No Abstract] [Full Text] [Related]
22. Impact of tanezumab on health status, non-work activities and work productivity in adults with moderate-to-severe osteoarthritis.
Conaghan PG; Abraham L; Viktrup L; Cislo P
BMC Musculoskelet Disord; 2022 Feb; 23(1):106. PubMed ID: 35105318
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis.
Birbara C; Dabezies EJ; Burr AM; Fountaine RJ; Smith MD; Brown MT; West CR; Arends RH; Verburg KM
J Pain Res; 2018; 11():151-164. PubMed ID: 29386912
[TBL] [Abstract][Full Text] [Related]
24. Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study.
Nagashima H; Suzuki M; Araki S; Yamabe T; Muto C;
Osteoarthritis Cartilage; 2011 Dec; 19(12):1405-12. PubMed ID: 22004765
[TBL] [Abstract][Full Text] [Related]
25. Predicting Treatment Responses in Patients With Osteoarthritis: Results From Two Phase III Tanezumab Randomized Clinical Trials.
Colloca L; Dworkin RH; Farrar JT; Tive L; Yang J; Viktrup L; Dasic G; West CR; Whalen E; Brown MT; Gilbert SA; Verburg KM
Clin Pharmacol Ther; 2023 Apr; 113(4):878-886. PubMed ID: 36621827
[TBL] [Abstract][Full Text] [Related]
26. Tanezumab for the treatment of pain from osteoarthritis of the knee.
Lane NE; Schnitzer TJ; Birbara CA; Mokhtarani M; Shelton DL; Smith MD; Brown MT
N Engl J Med; 2010 Oct; 363(16):1521-31. PubMed ID: 20942668
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Safety and Efficacy of Fulranumab in Patients With Moderate-to-Severe Osteoarthritis Pain: A Phase II Randomized, Double-Blind, Placebo-Controlled Extension Study.
Sanga P; Katz N; Polverejan E; Wang S; Kelly KM; Haeussler J; Thipphawong J
Arthritis Rheumatol; 2017 Apr; 69(4):763-773. PubMed ID: 27748055
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and Safety of Tanezumab on Osteoarthritis Knee and Hip Pains: A Meta-Analysis of Randomized Controlled Trials.
Chen J; Li J; Li R; Wang H; Yang J; Xu J; Zha Z
Pain Med; 2017 Feb; 18(2):374-385. PubMed ID: 28034979
[TBL] [Abstract][Full Text] [Related]
29. Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients with Osteoarthritis.
Schnitzer TJ; Berenbaum F; Conaghan PG; Dworkin RH; Gatti D; Yang R; Viktrup L; Davignon I; West CR; Verburg KM
Rheumatol Ther; 2021 Dec; 8(4):1759-1774. PubMed ID: 34606077
[TBL] [Abstract][Full Text] [Related]
30. The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Dakin P; DiMartino SJ; Gao H; Maloney J; Kivitz AJ; Schnitzer TJ; Stahl N; Yancopoulos GD; Geba GP
Arthritis Rheumatol; 2019 Nov; 71(11):1824-1834. PubMed ID: 31207169
[TBL] [Abstract][Full Text] [Related]
31. Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with Osteoarthritis.
Brown MT; Cornblath DR; Koltzenburg M; Gorson KC; Hickman A; Pixton GC; Gaitonde P; Viktrup L; West CR
Clin Drug Investig; 2023 Jul; 43(7):551-563. PubMed ID: 37460782
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of fulranumab in osteoarthritis of the hip and knee: results from four early terminated phase III randomized studies.
Kelly KM; Sanga P; Zaki N; Wang S; Haeussler J; Louie J; Thipphawong J
Curr Med Res Opin; 2019 Dec; 35(12):2117-2127. PubMed ID: 31387410
[No Abstract] [Full Text] [Related]
33. Characterizing 16-Week Responder Profiles Using Group-Based Trajectory Modeling in Over 4300 Clinical Trial Participants Receiving Pharmaceutical Treatment for Moderate to Severe Osteoarthritis.
Schnitzer TJ; Bonfanti G; Atkinson J; Donevan S; Viktrup L; Barroso J; Whalen E; Edwards RA
Adv Ther; 2022 Oct; 39(10):4742-4756. PubMed ID: 35960482
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of Various Dosages and Administration Methods of Tanezumab for the Treatment of Pain in Knee and Hip Osteoarthritis: a Network Meta-Analysis.
Cai YZ; Nie LY; Ruan JQ; Zhao K
Clin Ther; 2021 Dec; 43(12):2116-2126. PubMed ID: 34819241
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials.
Baraf HS; Gloth FM; Barthel HR; Gold MS; Altman RD
Drugs Aging; 2011 Jan; 28(1):27-40. PubMed ID: 21174485
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study.
Gibofsky A; Hochberg MC; Jaros MJ; Young CL
Curr Med Res Opin; 2014 Sep; 30(9):1883-93. PubMed ID: 25050589
[TBL] [Abstract][Full Text] [Related]
37. Total Serum Testosterone and Western Ontario and McMaster Universities Osteoarthritis Index Pain and Function Among Older Men and Women With Severe Knee Osteoarthritis.
Freystaetter G; Fischer K; Orav EJ; Egli A; Theiler R; Münzer T; Felson DT; Bischoff-Ferrari HA
Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1511-1518. PubMed ID: 31557423
[TBL] [Abstract][Full Text] [Related]
38. Relative Efficacy and Safety of Tanezumab for Osteoarthritis: A Systematic Review and Meta-analysis of Randomized-Controlled Trials.
Zhang B; Tian X; Qu Z; Liu J; Yang L
Clin J Pain; 2021 Dec; 37(12):914-924. PubMed ID: 34608021
[TBL] [Abstract][Full Text] [Related]
39. A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee.
Schnitzer TJ; Marks JA
Osteoarthritis Cartilage; 2015 Jan; 23 Suppl 1():S8-17. PubMed ID: 25527221
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study.
Altman R; Hochberg M; Gibofsky A; Jaros M; Young C
Curr Med Res Opin; 2015 Dec; 31(12):2331-43. PubMed ID: 26503347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
